Skip to search formSkip to main contentSkip to account menu

radolmidine

Known as: 2,3-dihydro-3-(1H-imidazol-4-ylmethyl)-1H-indan-5-ol, Fadolmidine 
National Institutes of Health

Related topics

Related topics

4 relations
Fadolmidine Hydrochloride

Broader (2)

ImidazolesIndans

Narrower (1)

MPV 2426

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Results of a Phase I clinical trial of intrathecal fadolmidine, a novel alpha2-adrenoceptor agonist with potential as a spinal analgesic: A-506
2006
2006
Results of a phase II clinical trial of intrathecal fadolmidine, a novel alpha2-adrenoceptor agonist with potential as a spinal analgesic, in combination with bupivacaine: A-507
2006
2006
Preclinical pharmacology of intrathecal fadolmidine, a novel alpha2-adrenoceptor agonist with potential as a spinal analgesic, in a rodent model: A-605
2001
2001
Basic Science (27)
Effects of radolmidine, a novel α2-adrenergicagonist compared with dexmedetomidine in different pain models in the rat… 
1999
1999
Intraspinal, 3 in the manufacture of intrathecal or epidural administration for pharmaceutical (1H-imidazol-4-ylmethyl) - indan-5-ol applications